
Supernus Pharmaceuticals (SUPN) has had the highest return between 2002 and 2026 by a US stock in the Nasdaq Composite (IXIC), returning 14,859,900%.
| ASSET | YEARS | % RETURN |
|---|---|---|
Supernus Pharmaceuticals (SUPN) | 2002-2026 | 14,859,900% |
Mesoblast (MESO) | 2002-2026 | 13,269,900% |
Hirequest (HQI) | 2002-2026 | 7,079,900% |
Avita Medical (RCEL) | 2002-2026 | 3,907,400% |
OPTIMIZERx (OPRX) | 2002-2026 | 3,669,900% |
MiMedx (MDXG) | 2002-2026 | 802,400% |
NetEase (NTES) | 2002-2026 | 424,136.11% |
Addex Therapeutics (ADXN) | 2002-2026 | 225,455.56% |
Monster Beverage (MNST) | 2002-2026 | 210,126.24% |
Riot Platforms (RIOT) | 2002-2026 | 188,287.1% |
A2Z Smart Technologies (AZ) | 2002-2026 | 146,927.03% |
Alphatec (ATEC) | 2002-2026 | 135,861.54% |
Oramed Pharmaceuticals (ORMP) | 2002-2026 | 127,831.03% |
Immatics (IMTX) | 2002-2026 | 127,700% |
Apple (AAPL) | 2002-2026 | 108,024.43% |
Paysign (PAYS) | 2002-2026 | 95,100% |
Xcel Brands (XELB) | 2002-2026 | 66,680% |
Lexaria Bioscience (LEXX) | 2002-2026 | 66,168.66% |
Jade Biosciences (JBIO) | 2002-2026 | 61,976.92% |
LiveOne (LVO) | 2002-2026 | 59,300% |
Altimmune (ALT) | 2002-2026 | 56,624.14% |
NeoGenomics (NEO) | 2002-2026 | 55,525% |
Netflix (NFLX) | 2002-2026 | 53,662.98% |
Evogene (EVGN) | 2002-2026 | 52,757.14% |
Amazon (AMZN) | 2002-2026 | 48,667.37% |